Mkts

Arcadia Biosciences, Inc.

NASDAQ: RKDA
$0.16-0.01 (-3.54%)
As of Nov 6, 4:00 PM ET

Key statistics

Day range
0.160.17
52-week range
0.114.18
Today
Open0.16
Previous close0.16
Volume—
Valuation
Market cap387.9K
P/E ratio—
EPS (TTM)-4.55
Income & risk
Dividend / yield—
Beta0.63
Avg volume1.43M
Discussion

RKDA News

Stories mentioning RKDA from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue1,100901.001,3021,4551,2001,2151,5371,306
Cost of Goods Sold700.00708.00884.00824.00682.00827.001,032633.00
Gross Profit400.00193.00418.00631.00518.00388.00505.00673.00
Operating Expenses
Research & Development0.000.009.000.0013.0024.0010.00
Sales General & Admin1,1791,5701,5702,1231,7382,6552,2412,683
Total Operating Expenses
Operating Income (Loss)(779.00)(1,377)(1,152)(501.00)530.00(2,280)(1,760)1,980
Interest Income
Interest Expense
Other Expense(1,504)(460.00)1,6981,0710.00(137.00)15.00150.00
Pretax Income(1,182)1,850
Tax Provision0.000.00
Net Income (Loss)(4,385)(1,336)856.00(4,458)2,599(4,064)(1,612)1,061
Earnings Per Share (Basic)(2.11)(0.98)0.63(3.26)1.90(2.98)(1.18)0.78
Earnings Per Share (Diluted)(2.11)(0.98)0.62(3.26)1.90(2.98)(1.18)0.78
Weighted Average Shares Outstanding (Basic)2,0831,3681,3671,3671,3661,3631,3641,363
Weighted Average Shares Outstanding (Diluted)2,0831,3681,3721,3671,3661,3631,3641,363

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About RKDA

Arcadia Biosciences, Inc. (NASDAQ: RKDA) is a stock listed on the Nasdaq Stock Market under the ticker symbol RKDA. It last traded at $0.1600 (Nov 6, 2026, 4:00 PM ET), down 3.5% on the day. That gives Arcadia Biosciences a market capitalisation of $387.9K.

Over the past 52 weeks RKDA has traded between $0.1100 and $4.18.

Revenue for the quarter ended Mar 31, 2026 was $1.1M; a net loss of $4.4M. Revenue was down 8.3% from $1.2M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$1.1M-$4.4M-398.6%
Dec 31, 2025$901.0K-$1.3M-148.3%
Sep 30, 2025$1.3M$856.0K65.7%
Jun 30, 2025$1.5M-$4.5M-306.4%

From Arcadia Biosciences’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…